| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | 0.16 | 0.0002 |
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0006 |
| mRNA | IOX2 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0008 |
| mRNA | BRD-K34485477 | CTRPv2 | pan-cancer | AAC | 0.25 | 0.001 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | Fumonisin B1 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |
| mRNA | alisertib:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |
| mRNA | RDEA119 | FIMM | pan-cancer | AAC | -0.46 | 0.004 |
| mRNA | CCT036477 | CTRPv2 | pan-cancer | AAC | -0.099 | 0.004 |
| mRNA | BIRB 0796 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.004 |